Skip to content

Psychobiological Markers to Improve Diagnosis and to Predict Affective Episodes in Bipolar Disorder

Psychobiological Markers to Improve Diagnosis and to Predict Affective Episodes in Bipolar Disorder

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07427966
Acronym
MoodCatcher
Enrollment
600
Registered
2026-02-23
Start date
2026-04-01
Completion date
2030-12-01
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder (BD), Major Depressive Disorder, Mood Disorders

Keywords

Mood disorders, Bipolar Disorder, Affective disorder assesment, Major depressive disorder, Cognition, Sleep, Activity

Brief summary

This trial has two studies. In study 1, the investigators will explore the relationships between three psychobiological factors (sleep patterns, motor activity, and decision-making ability). The investigators aim to investigate how these factors interact in BD patients. This understanding will facilitate the distinction of BD patients from patients with recurrent depressive disorder (MDD) and healthy controls. In study 2, the investigators will continue following patients with bipolar disorder and use the interplay between the three psychobiological factors to develop early markers of full-blown affective episodes.

Interventions

None listed

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

For all participants: * Participants must be capable of giving informed consent. * Participants must be able to understand and follow the instructions in the project. * Access to a smartphone and ability to use a smartphone and actimeter. For patients with bipolar disorder * Confirmed diagnosis of bipolar disorder (type 1 or type 2) according to ICD-10 after completion of an assessment at a psychiatric clinic in the Stockholm Region. * Patients must be euthymic (stable and free from affective episodes) at the time of inclusion. * Consent for the research team to access relevant clinical data from patient records. For patients with recurrent depression * Confirmed diagnosis of recurrent depression according to ICD-10 after completion of an assessment at a psychiatric clinic in Region Stockholm. * Patients must have been referred for diagnostic assessment with the question of bipolar disorder. * Patients must be euthymic (stable and free from affective episodes) at the time of inclusion.

Exclusion criteria

Common to all participants: * Active substance abuse or dependence (alcohol or other substances). * Neurological disease or cognitive impairment that may affect study results or compliance with study procedures. * Inability to use a smartphone and smartwatch as required by the study. * Inability to provide valid informed consent. * Inability to understand and follow the study instructions (good knowledge of Swedish is required). For adults without psychiatric illness: * Current or previous psychiatric diagnosis. For patients with bipolar disorder and patients with recurrent depression: * Patients who are in an active affective episode (mania, hypomania or depression) at the time of recruitment.

Design outcomes

Primary

MeasureTime frameDescription
Sleep duration12 weeks for study 1; 1 year for study 2Smartwatch measure of sleep duration.
Effort discounting12 weeks for study 1; 1 year for study 2We will administer an effort discounting task and use computational modeling to extract an effort discounting parameter.
Foraging exit threshold12 weeks for study 1; 1 year for study 2We will administer foraging task and calculate a foraging exit threshold.
Sleep quality12 weeks for study 1; 1 year for study 2Smartwatch measure of sleep quality.
Sleep onset12 weeks for study 1; 1 year for study 2Smartwatch measure of sleep onset.
Motor activity12 weeks for study 1; 1 year for study 2Smartwatch data on number of steps each half time of the day
Learning rate12 weeks for study 1; 1 year for study 2We will administer a reward learning task and use computational modeling to extract a learning rate.
Reward sensitivity12 weeks for study 1; 1 year for study 2We will administer a valence go/no go task and use computational model to extract reward sensitivity.
Motivational bias12 weeks for study 1; 1 year for study 2We will administer a valence go/no go task and use computational model to extract a motivational bias.

Secondary

MeasureTime frameDescription
Questionnaires12 weeks for study 1; 1 year for study 2Altman Self-Rating Mania Scale (ASRM)
Questionnaire12 weeks for study 1; 1 year for study 2Karolinska Sleep Questionnaire (KSQ)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026